NO914481L - PROCEDURE FOR MANUFACTURING AND USING SUBSTITUTED AZOLS - Google Patents

PROCEDURE FOR MANUFACTURING AND USING SUBSTITUTED AZOLS

Info

Publication number
NO914481L
NO914481L NO91914481A NO914481A NO914481L NO 914481 L NO914481 L NO 914481L NO 91914481 A NO91914481 A NO 91914481A NO 914481 A NO914481 A NO 914481A NO 914481 L NO914481 L NO 914481L
Authority
NO
Norway
Prior art keywords
mean
azols
substituted
procedure
manufacturing
Prior art date
Application number
NO91914481A
Other languages
Norwegian (no)
Other versions
NO914481D0 (en
Inventor
Heinz-Werner Kleemann
Hermann Gerhards
Bernward Schoelkens
Original Assignee
Hoechst Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoechst Ag filed Critical Hoechst Ag
Publication of NO914481D0 publication Critical patent/NO914481D0/en
Publication of NO914481L publication Critical patent/NO914481L/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/10—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a carbon chain containing aromatic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/66—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D233/68—Halogen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/66—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D233/70—One oxygen atom
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/10—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing aromatic rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)

Abstract

Azoler med formel. der X, Y og Z står for N eller CR, der Rblant annet kan bety hydrogen, klor, metoksy, benzyloksy. L kan blant annet bety -CE-, A betyr en aromatisk eller heterocykllsk rest og T en binding eller en toverdig rest, Ri kan blant annet bety (CR3-C5 )-alkyl og E kan blant annet bety følgende formel. Det blir beskrevet en fremgangsmåte for fremstilling, og midler som inneholder disse forbindelsene og deres anvendelse som helnlngsmiddel.Azoles with formula. where X, Y and Z stand for N or CR, where R may mean hydrogen, chlorine, methoxy, benzyloxy, among others. L can mean -CE-, A means an aromatic or heterocyclic radical and T a bond or a divalent radical, R 1 can mean (CR 3 -C 5) -alkyl and E can mean the following formula. A process for its preparation and compositions containing these compounds and their use as a healing agent are described.

NO91914481A 1990-11-16 1991-11-15 PROCEDURE FOR MANUFACTURING AND USING SUBSTITUTED AZOLS NO914481L (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE4036645A DE4036645A1 (en) 1990-11-16 1990-11-16 SUBSTITUTED AZOLE, METHOD FOR THE PRODUCTION THEREOF, THE AGENT, AND THEIR USE THEREOF

Publications (2)

Publication Number Publication Date
NO914481D0 NO914481D0 (en) 1991-11-15
NO914481L true NO914481L (en) 1992-05-18

Family

ID=6418438

Family Applications (1)

Application Number Title Priority Date Filing Date
NO91914481A NO914481L (en) 1990-11-16 1991-11-15 PROCEDURE FOR MANUFACTURING AND USING SUBSTITUTED AZOLS

Country Status (17)

Country Link
EP (1) EP0485929A1 (en)
JP (1) JPH04283569A (en)
KR (1) KR920009802A (en)
CN (1) CN1061410A (en)
AU (1) AU8785591A (en)
BR (1) BR9104948A (en)
CA (1) CA2055636A1 (en)
CS (1) CS347091A3 (en)
DE (1) DE4036645A1 (en)
FI (1) FI915381A7 (en)
HU (1) HUT59673A (en)
IE (1) IE913991A1 (en)
IL (1) IL100058A0 (en)
MX (1) MX9102098A (en)
NO (1) NO914481L (en)
PT (1) PT99521A (en)
ZA (1) ZA919059B (en)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4036706A1 (en) * 1990-11-17 1992-05-21 Hoechst Ag METHOD FOR THE TREATMENT OF CARDIALS AND VASCULAR HYPERTROPHY AND HYPERPLASIA
US5616599A (en) * 1991-02-21 1997-04-01 Sankyo Company, Limited Angiotensin II antagosist 1-biphenylmethylimidazole compounds and their therapeutic use
DE4200954A1 (en) * 1991-04-26 1992-10-29 Bayer Ag New heterocycle-substd. phenylacetic acid derivs. - are angiotensin II antagonists for treating arterial hypertonia, atherosclerosis, coronary insufficiency, ischaemic cerebral disorders, respiratory disorders, etc.
DE4309968A1 (en) * 1993-03-26 1994-09-29 Bayer Ag Phenylglycinamides of heterocyclic substituted phenylacetic acid derivatives
JP3501484B2 (en) * 1992-12-17 2004-03-02 三共株式会社 Biphenyl derivative
US5300668A (en) * 1993-03-10 1994-04-05 Pfizer Inc. Certain esters of 1-(4-X-methylphenyl)cyclopent-3-ene-1-carboxylic acid, wherein X is a trialkylsilyloxy, bromo or hydroxy group, as intermediates
DE19645313A1 (en) 1996-11-04 1998-05-07 Basf Ag Substituted 3-benzylpyrazoles
SE9903028D0 (en) 1999-08-27 1999-08-27 Astra Ab New use
PE20070404A1 (en) 2005-07-29 2007-05-10 Wyeth Corp COMPOUNDS DERIVED FROM CYANOPYRROL-SULFONAMIDE AS MODULATORS OF THE PROGESTERONE RECEPTOR
PE20070182A1 (en) 2005-07-29 2007-03-06 Wyeth Corp CYANOPYRROL-PHENYL AMIDE DERIVATIVES AS PROGESTERONE RECEPTOR MODULATORS
MX2009013293A (en) 2007-06-04 2010-02-15 Synergy Pharmaceuticals Inc Agonists of guanylate cyclase useful for the treatment of gastrointestinal disorders, inflammation, cancer and other disorders.
US8969514B2 (en) 2007-06-04 2015-03-03 Synergy Pharmaceuticals, Inc. Agonists of guanylate cyclase useful for the treatment of hypercholesterolemia, atherosclerosis, coronary heart disease, gallstone, obesity and other cardiovascular diseases
EP2810951B1 (en) 2008-06-04 2017-03-15 Synergy Pharmaceuticals Inc. Agonists of guanylate cyclase useful for the treatment of gastrointestinal disorders, inflammation, cancer and other disorders
CA2730603C (en) 2008-07-16 2019-09-24 Synergy Pharmaceuticals Inc. Agonists of guanylate cyclase useful for the treatment of gastrointestinal disorders, inflammation, cancer and other disorders
US9616097B2 (en) 2010-09-15 2017-04-11 Synergy Pharmaceuticals, Inc. Formulations of guanylate cyclase C agonists and methods of use
JP2016514671A (en) 2013-03-15 2016-05-23 シナジー ファーマシューティカルズ インコーポレイテッド Guanylate cyclase agonists and uses thereof
JP2016514670A (en) 2013-03-15 2016-05-23 シナジー ファーマシューティカルズ インコーポレイテッド Guanylate cyclase receptor agonists in combination with other drugs
EA201592263A1 (en) 2013-06-05 2016-05-31 Синерджи Фармасьютикалз, Инк. ULTRASCULAR AGONISTS OF GUANYLACYCLASE C, METHOD OF THEIR RECEIVING AND USING
WO2023274257A1 (en) * 2021-07-01 2023-01-05 诸葛国琴 Imidazole compound, and intermediate and application thereof

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1329614C (en) * 1987-05-02 1994-05-17 Rainer Buerstinghaus N-substituted azoles
CA1338238C (en) * 1988-01-07 1996-04-09 David John Carini Angiotensin ii receptor blocking imidazoles and combinations thereof with diuretics and nsaids

Also Published As

Publication number Publication date
CS347091A3 (en) 1992-06-17
MX9102098A (en) 1992-07-08
EP0485929A1 (en) 1992-05-20
PT99521A (en) 1992-09-30
BR9104948A (en) 1992-06-23
CN1061410A (en) 1992-05-27
CA2055636A1 (en) 1992-05-17
IL100058A0 (en) 1992-08-18
FI915381L (en) 1992-05-17
FI915381A7 (en) 1992-05-17
IE913991A1 (en) 1992-05-20
DE4036645A1 (en) 1992-05-21
JPH04283569A (en) 1992-10-08
FI915381A0 (en) 1991-11-14
NO914481D0 (en) 1991-11-15
ZA919059B (en) 1992-07-29
HUT59673A (en) 1992-06-29
KR920009802A (en) 1992-06-25
AU8785591A (en) 1992-05-21
HU913583D0 (en) 1992-01-28

Similar Documents

Publication Publication Date Title
DK0503162T3 (en) Asole derivatives, processes for their preparation and their use
NO20025821L (en) 2-aminocarbonyl-9H-purine
ATE98290T1 (en) DIFLUOROMETHYL COMPOUNDS.
EP0528858A4 (en) Inhibitors of dipeptidyl-aminopeptidase type iv
CA2274464A1 (en) Ketobenzamides as calpain inhibitors
CA2040905A1 (en) Carbohydrate derivatives comprising a trisaccharide unit
CA2017934A1 (en) Nitrogen-containing titanocenes, and the use thereof
CA2017932A1 (en) Oxygen-containing titanocenes, and the use thereof
ATE144498T1 (en) PREPARATION OF SUBSTITUTED PIPERIDINES
NO971625L (en) Novel peptides with immunomodulatory effects
MY131693A (en) Arylacetic acid derivatives
CA2298461A1 (en) Heterocyclic substituted 4-benzoyl-pyrazole as herbicides
NO884523L (en) IODATED POLYMERS, THE PROCEDURE FOR THEIR PREPARATION AND THEIR USE AS CONTRACTING AGENTS.
MX9702203A (en) Substituted pyrazolyl-pyrazole derivatives, processes for their preparation and their use as agents with herbicidal action.
CA2188796A1 (en) Heterocyclylbenzonitriles
CA2051894A1 (en) Substituted 5-Alkoxy-1,2,4-Triazol-3-(Thi)Ones
PL348356A1 (en) Substituted 1,3,5-triazines
NO943765L (en) Aryloksybenzen-herbicidmidler
NO950665L (en) New polyiodized compounds, methods of their preparation and contrast agents containing them
DK0658557T3 (en) Eburnan derivatives, process for preparing such derivatives and pharmaceutical compositions containing them
DE59107500D1 (en) New beta-galactosidase substrates for CEDIA
MY107258A (en) 1-methoxypyrimidinyl-n-nitrophenyl-1h-1,2,4-triazole-3- sulphonamides, processes for their preparation and their use as herbicides.
IL67400A0 (en) 3,7alpha-diazacyclohepta(j,k)fluorene derivatives,their preparation and pharmaceutical compositions containing them
AU579997B2 (en) Iminosulphonamides and processes for the manufacture thereof, pharmaceutical preparations containing such compounds, and their use
EP0392680A3 (en) Aromatic compounds